CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information


Laboratorios Grin, Lupin’s subsidiary in Mexico, remains one of the key players in the Ophthalmic segment and continues to deliver steady growth. In the past 12 months, despite the manufacturing plant being shut for seven months, revenues grew by 5%, with sales of MXP 674 million delivering a healthy increase on all profitability parameters above industry benchmarks.

The Company launched two preservative-free ophthalmic soutions for the treatment of Glaucoma. The Mexican pharmaceutical market is expected to grow mainly in the Antiviral, Diabetes, Oncology and Cardio-Metabolic therapeutic areas with a shift towards greater export diversity.